21.60
+0.40
+(1.89%)
As of 8:00:27 AM GMT+2. Market Open.
Loading Chart for 82P.BE
- Previous Close
21.20 - Open
21.60 - Bid 21.60 x --
- Ask 21.80 x --
- Day's Range
21.60 - 21.60 - 52 Week Range
11.20 - 29.00 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 5, 2025 - May 9, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 82P.BE
View MorePerformance Overview: 82P.BE
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
82P.BE
15.51%
S&P 500 (^GSPC)
10.30%
1-Year Return
82P.BE
14.29%
S&P 500 (^GSPC)
5.05%
3-Year Return
82P.BE
68.92%
S&P 500 (^GSPC)
20.10%
5-Year Return
82P.BE
23.62%
S&P 500 (^GSPC)
83.53%
Compare To: 82P.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
21.60
+1.89%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
70.00
+0.72%
Mkt Cap EUR 3.526B
Industry Drug Manufacturers—Specialty & Generic
19.85
+0.23%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
6.20
+4.20%
Mkt Cap EUR 3.084B
Industry Drug Manufacturers—Specialty & Generic
27.00
-0.74%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
14.70
+2.08%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
20.49
-1.87%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
6.20
+0.81%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
23.80
+1.71%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: 82P.BE
View MoreValuation Measures
As of 4/16/2025
Market Cap
1.00B
Enterprise Value
1.14B
Trailing P/E
--
Forward P/E
8.76
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.58
Price/Book (mrq)
1.42
Enterprise Value/Revenue
1.84
Enterprise Value/EBITDA
44.19
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--